Detalhe da pesquisa
1.
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims.
Pharmacoepidemiol Drug Saf
; 33(1): e5690, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669770
2.
Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.
Gynecol Endocrinol
; 38(11): 891-910, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075250
3.
The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment.
J Sex Med
; 14(3): 413-424, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202320
4.
The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
J Sex Med
; 14(3): 425-433, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202319
5.
TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.
J Sex Med
; 13(12): 1930-1937, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27692842
6.
The effect of renal and hepatic impairment on the pharmacokinetics of ospemifene, a tissue-selective estrogen agonist/antagonist.
Am J Ther
; 22(3): 171-81, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24413373
7.
Assessment of ospemifene or lubricants on clinical signs of VVA.
J Sex Med
; 11(4): 1033-1041, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443923
8.
Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users.
J Womens Health (Larchmt)
; 32(7): 808-815, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253139
9.
Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms.
Menopause
; 29(3): 304-308, 2022 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213517
10.
Response and Rebuttal to Editorial Comment on TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women with Vulvar and Vaginal Atrophy: The REJOICE Trial.
J Sex Med
; 13(12): 1940-1941, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914565
11.
Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert.
Menopause
; 28(9): 998-1003, 2021 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34054104
12.
Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system.
Contraception
; 104(3): 229-234, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785318
13.
Effects of combined 17ß-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial.
Menopause
; 28(1): 32-39, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32932401
14.
Breast effects of oral, combined 17ß-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial.
Menopause
; 27(12): 1388-1395, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842052
15.
17ß-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.
Menopause
; 27(12): 1382-1387, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740481
16.
TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial.
Menopause
; 27(11): 1236-1241, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110039
17.
Physical characteristics and properties of estradiol softgel vaginal inserts.
Menopause
; 27(2): 150-155, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31663981
18.
Endometrial safety and bleeding profile of a 17ß-estradiol/progesterone oral softgel capsule (TX-001HR).
Menopause
; 27(4): 410-417, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913228
19.
Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.
J Womens Health (Larchmt)
; 28(2): 237-243, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30484734
20.
Oral 17ß-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
Menopause
; 26(5): 506-512, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30489424